Tag: pharmaceuticals
-
Trial to Test Inhaled Insulin, App for Diabetes Mgmt
A clinical trial is planned to test the benefits of managing type 2 diabetes with an inhaled formulation of insulin and a smartphone app.
-
Migraine Treatment Shown Effective in Late Trial
Results of a clinical trial show a single dose of new drug relieved migraine pain among more people with the condition, compared to a placebo.
-
Gene-Edited Skin Grafts Shown to Control Glucose Levels
Skin grafts derived from genetically edited stem cells were shown in tests with lab mice to reduce glucose levels and weight gain that result from a high-fat diet.
-
Many Surgical Opioid Drugs Go Unused, Not Disposed
A review of studies that track the use and disposition of opioid pain drugs following surgery shows a large percentage of the pills go unused and few are stored properly.
-
University, Company Employ AI for Anti-Aging Drugs
The medical analytics company Insilico Medicine is partnering with a university in Denmark to apply artificial intelligence to find new treatments for diseases associated with early aging.
-
Gene Editing, Therapy Company Gains $83.5M in Venture Funds
A biotechnology company designing treatments with gene edits and transfers using benign viruses is raising $83.5 million in its second venture funding round.
-
Life Science Execs: Financial, IP Info Top Hacker Targets
Technology executives at pharmaceutical and medical device enterprises in the U.S. say financial and intellectual property assets are their top targets for hackers, according to survey results released today.
-
RNA Vaccine for Rabies Found Safe, Generates Antibodies
A vaccine to prevent rabies made from messenger RNA, genetic material transcribed from DNA, was shown in a clinical trial to be generally safe and able under some conditions to induce antibodies.
-
Tough Ingested Hydrogels Designed for Long-Term Drugs
A medical engineering team developed and tested in animals a new water-based polymer material to deliver drugs for long-term release in the stomach.
-
Faster Process Devised for Targeted Antibodies
Researchers in the U.S. and U.K. designed techniques for quickly generating highly targeted antibodies in the lab, which can speed production of new vaccines and therapies.